AIMS: Coronary artery bypass graft (CABG) surgery is the standard of care for the management of patients with severe three-vessel and left main coronary artery disease (CAD). However, the optimal strategy for management of patients with CAD and severe left ventricular (LV) dysfunction [ejection fraction (EF) ≤35%] is not clear. A meta-analysis of observational studies was performed to determine the operative mortality and long-term (5-year actuarial survival) outcomes among patients with severe LV dysfunction undergoing CABG. METHODS AND RESULTS: A systematic computerized literature search was performed and observational studies consisting of patients undergoing isolated CABG for CAD and severe LV dysfunction were included. Studies that did not report operative mortality, long-term (≥1 year) survival data, or pre-operative EF and multiple studies from the same group were excluded. In total, 4119 patients from 26 observational clinical studies were included. The estimated mean age was 63.9 years and 82.4% of patients were men. The mean (estimate) pre-operative EF was 24.7% (95% CI 22.5-27.0%). The operative mortality among patients (26 studies, n= 3621) who underwent on-pump CABG was 5.4%, n= 189 (95% CI 4.5-6.4%). The 5-year actuarial survival among patients (13 studies, n= 1980) who underwent on-pump CABG was 73.4%, n= 1483 (95% CI 68.7-77.7%). Patients who underwent off-pump CABG (7 studies, n= 498) tended to have reduced operative mortality of 4.4%, n= 20 (95% CI 2.8-6.4%). The mean (estimate) post-operative EF was 35.19% (95% CI 31.95-38.43%). CONCLUSION: The present meta-analysis demonstrates that based on data from available observational clinical studies, CABG can be performed with acceptable operative mortality and 5-year actuarial survival in patients with severe LV dysfunction.
AIMS: Coronary artery bypass graft (CABG) surgery is the standard of care for the management of patients with severe three-vessel and left main coronary artery disease (CAD). However, the optimal strategy for management of patients with CAD and severe left ventricular (LV) dysfunction [ejection fraction (EF) ≤35%] is not clear. A meta-analysis of observational studies was performed to determine the operative mortality and long-term (5-year actuarial survival) outcomes among patients with severe LV dysfunction undergoing CABG. METHODS AND RESULTS: A systematic computerized literature search was performed and observational studies consisting of patients undergoing isolated CABG for CAD and severe LV dysfunction were included. Studies that did not report operative mortality, long-term (≥1 year) survival data, or pre-operative EF and multiple studies from the same group were excluded. In total, 4119 patients from 26 observational clinical studies were included. The estimated mean age was 63.9 years and 82.4% of patients were men. The mean (estimate) pre-operative EF was 24.7% (95% CI 22.5-27.0%). The operative mortality among patients (26 studies, n= 3621) who underwent on-pump CABG was 5.4%, n= 189 (95% CI 4.5-6.4%). The 5-year actuarial survival among patients (13 studies, n= 1980) who underwent on-pump CABG was 73.4%, n= 1483 (95% CI 68.7-77.7%). Patients who underwent off-pump CABG (7 studies, n= 498) tended to have reduced operative mortality of 4.4%, n= 20 (95% CI 2.8-6.4%). The mean (estimate) post-operative EF was 35.19% (95% CI 31.95-38.43%). CONCLUSION: The present meta-analysis demonstrates that based on data from available observational clinical studies, CABG can be performed with acceptable operative mortality and 5-year actuarial survival in patients with severe LV dysfunction.
Authors: S F Oliveira; A D Jatene; M C Solimene; S A de Oliveira; C Meneguetti; F B Jatene; N G Stolf; F Pileggi; J A Ramires Journal: Heart Surg Forum Date: 1999 Impact factor: 0.676
Authors: Fatih Lslamoglu; Anil Ziya Apaydin; Hakan Posacioglu; Mustafa Ozbaran; Ahmet Hamulu; Suat Buket; Ali Telli; Isa Durmaz Journal: Jpn Heart J Date: 2002-07
Authors: R Lorusso; G La Canna; C Ceconi; V Borghetti; P Totaro; G Parrinello; G Coletti; G Minzioni Journal: Eur J Cardiothorac Surg Date: 2001-11 Impact factor: 4.191
Authors: John Alfred Carr; Benjamin E Haithcock; Gaetano Paone; Alvise F Bernabei; Norman A Silverman Journal: Ann Thorac Surg Date: 2002-11 Impact factor: 4.330
Authors: Raimondo Ascione; Pradeep Narayan; Chris A Rogers; Kelvin H H Lim; Radek Capoun; Gianni D Angelini Journal: Ann Thorac Surg Date: 2003-09 Impact factor: 4.330
Authors: C Selim Isbir; Tekin Yildirim; Serdar Akgun; Ali Civelek; Nazan Aksoy; Mine Oz; Sinan Arsan Journal: Int J Cardiol Date: 2003-08 Impact factor: 4.164